Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  229 results for ""Angiotensin II Type 1 Receptor Blockers""

Your Filters

Subject : neprilysin
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Angiotensin receptor-neprilysin inhibition and improved ventricular-arterial coupling in heart failure with reduced ejection fraction.

  • Authors : Stegmann T; Department of Cardiology, Leipzig University Hospital, Leipzig, Germany.; Parentin L

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/physiopathology ; Valsartan*/Valsartan*/Valsartan*/therapeutic use

  • Source: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2024 Dec 01; Vol. 327 (6), pp. H1477-H1489. Date of Electronic Publication: 2024 Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease.

  • Authors : Zhang Z; Department of Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.; Chen S

Subjects: Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/adverse effects ; Aminobutyrates*/Aminobutyrates*/Aminobutyrates*/therapeutic use ; Valsartan*/Valsartan*/Valsartan*/therapeutic use

  • Source: Journal of cardiovascular pharmacology and therapeutics [J Cardiovasc Pharmacol Ther] 2024 Jan-Dec; Vol. 29, pp. 10742484241265337. Date of Electronic Publication: 2024 Jul 21.Publisher: Sage Publications Country of Publication: United States NLM ID: 9602617 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Real-world experience of angiotensin receptor/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis.

Subjects: Aminobutyrates/Aminobutyrates/Aminobutyrates/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*therapeutic use

  • Source: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2021 Jul 02; Vol. 21 (1), pp. 324. Date of Electronic Publication: 2021 Jul 02.Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261

Record details

Read More Add to Saved list
×
Academic Journal

Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction.

  • Authors : Pericas P; Cardiology Department, Hospital Universitari Son Espases, Carretera de Valldemossa, 79, 07120, Palma, Balearic Islands, Spain. .; Grupo de investigación de Fisiopatología y Terapéutica Cardiovascular, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain. .

Subjects: Aminobutyrates/Aminobutyrates/Aminobutyrates/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Heart Failure/Heart Failure/Heart Failure/*drug therapy

  • Source: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension [High Blood Press Cardiovasc Prev] 2021 Mar; Vol. 28 (2), pp. 167-175. Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9421087 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Effects of angiotensin receptor neprilysin inhibition on pulmonary arterial stiffness in heart failure with reduced ejection fraction.

  • Authors : Yenerçağ M; Department of Cardiology, University of Health Sciences Samsun Training and Research Hospital, Baris Bulvari, No: 199, 55400, Samsun, Turkey.; Arslan U

Subjects: Aminobutyrates/Aminobutyrates/Aminobutyrates/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Heart Failure/Heart Failure/Heart Failure/*drug therapy

  • Source: The international journal of cardiovascular imaging [Int J Cardiovasc Imaging] 2021 Jan; Vol. 37 (1), pp. 165-173. Date of Electronic Publication: Publisher: Springer Country of Publication: United States NLM ID: 100969716 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Conflicting Perspectives on the Value of Neprilysin Inhibition in Heart Failure Revealed During Development of a Decision Aid Focusing on Patient Costs for Sacubitril/Valsartan.

  • Authors : Venechuk GE; Adult and Child Consortium for Outcomes Research and Delivery Science (G.E.V., L.A.A., D.D.M.), University of Colorado School of Medicine, Aurora.; Center for Demography of Health and Aging, University of Wisconsin-Madison (G.E.V.).

Subjects: Decision Support Techniques* ; Drug Costs* ; Health Expenditures*

  • Source: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2020 Sep; Vol. 13 (9), pp. e006255. Date of Electronic Publication: 2020 Aug 20.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101489148 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor.

  • Authors : Sun J; Shenzhen Salubris Pharmaceutical Co., Ltd., Shenzhen, Guangdong, China. Electronic address: .; Xu W

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Heart Failure/Heart Failure/Heart Failure/*drug therapy ; Neprilysin/Neprilysin/Neprilysin/*antagonists & inhibitors

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2020 Sep; Vol. 129, pp. 110410. Date of Electronic Publication: 2020 Jun 20.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan.

  • Authors : Hsiao FC; Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.; Wang CL

Subjects: Aminobutyrates/Aminobutyrates/Aminobutyrates/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Heart Failure/Heart Failure/Heart Failure/*drug therapy

  • Source: Journal of cardiovascular pharmacology and therapeutics [J Cardiovasc Pharmacol Ther] 2020 Mar; Vol. 25 (2), pp. 152-157. Date of Electronic Publication: 2019 Sep 12.Publisher: Sage Publications Country of Publication: United States NLM ID: 9602617 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Report

Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation.

  • Authors : Zern EK; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (E.K.Z., S.C., M.A.H., M.M.K.).; Cheng S

Subjects: Heart Transplantation* ; Waiting Lists*; Aminobutyrates/Aminobutyrates/Aminobutyrates/*therapeutic use

  • Source: Circulation. Heart failure [Circ Heart Fail] 2020 Feb; Vol. 13 (2), pp. e006696. Date of Electronic Publication: 2020 Feb 14.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101479941 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study.

  • Authors : Huo Y; Department of Cardiology, Peking University First Hospital, Beijing, China.; Li W

Subjects: Aminobutyrates/Aminobutyrates/Aminobutyrates/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/*therapeutic use

  • Source: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2019 Jan; Vol. 21 (1), pp. 67-76. Date of Electronic Publication: Publisher: Wiley Periodicals Inc Country of Publication: United States NLM ID: 100888554 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  229 results for ""Angiotensin II Type 1 Receptor Blockers""